According to a blog post on its site, Index Ventures has sold X01 Ltd to Janssen Pharmaceuticals Inc, a Johnson and Johnson subsidiary. No financial terms were disclosed. X01 is a cardiovascular drug startup. To read the announcement, visit here.
Johnson and Johnson is looking to sell most of its US feminine hygiene business, as it seeks to exit low-growth areas, but wants to keep its K-Y brand, writes Reuters. The diversified healthcare giant wants to unload its Stayfree and Carefree pads and o.b. tampons, according to Reuters.